Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01870375Completed
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Mucopolysaccharidosis Type IMucopolysaccharidosis Type IIMucopolysaccharidosis Type IV+2 more
StudydirectorStart date: 2009-09-01

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Chester B. Whitley, M.D., Ph.D.

University of Minnesota

Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IV+2 more

Worked with same sponsors:

Lysosomal Disease NetworkNational Center for Advancing Translational Sciences (NCATS)+4 more
Collaborated on 1 trial
Similarity Score54%

Paul Harmatz, M.D.

Oakland Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IV+2 more

Worked with same sponsors:

Lysosomal Disease NetworkNational Center for Advancing Translational Sciences (NCATS)+4 more
Collaborated on 1 trial
Similarity Score54%

Heather Lau, M.D.

New York University

Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IV+2 more

Worked with same sponsors:

Lysosomal Disease NetworkNational Center for Advancing Translational Sciences (NCATS)+4 more
Collaborated on 1 trial
Similarity Score54%

Michal Inbar-Feigenberg, M.D.

Hospital for Sick Children, Toronto, Ontario, CA

Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IV+2 more

Worked with same sponsors:

Lysosomal Disease NetworkNational Center for Advancing Translational Sciences (NCATS)+4 more
Collaborated on 1 trial
Similarity Score54%

Tippi C MacKenzie, MD

University of California, San Francisco

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis VI+1 more
Similarity Score24%

Paul Orchard, MD

Masonic Cancer Center, University of Minnesota

Related
9 trials

Shared therapeutic areas:

Mucopolysaccharidosis VIMucopolysaccharidosis IMucopolysaccharidosis II+1 more
Similarity Score24%

Lynda E Polgreen, MD, MS

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis VI

Worked with same sponsors:

National Center for Advancing Translational Sciences (NCATS)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+2 more
Similarity Score18%

Melissa Wasserstein, MD

Albert Einstein College of Medicine

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IIMucopolysaccharidosis VIMucopolysaccharidosis VII
Similarity Score18%

Paul Orchard, M.D.

Masonic Cancer Center, University of Minnesota

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IIMucopolysaccharidosis VIMucopolysaccharidosis VII
Similarity Score18%

Arndt Rolfs, Prof. Dr.

CENTOGENE GmbH Rostock

Related
4 trials

Shared therapeutic areas:

Mucopolysaccharidosis IIMucopolysaccharidosis IV
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01870375StudyDirector

Longitudinal Studies of Brain Structure and Function in MPS Disorders

Mucopolysaccharidosis Type IMucopolysaccharidosis Type IIMucopolysaccharidosis Type IV+2 more
Completed

All 1 trials loaded